查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017548

動物生長促效劑與生產力增強劑市場：2026-2032年全球市場預測（依產品類型、牲畜種類、製劑形式、應用及通路分類）

Animal Growth Promoters & Performance Enhancers Market by Product Type, Livestock Type, Formulation, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，動物生長促效劑和生產力增強劑市場價值將達到 190.8 億美元，到 2026 年將成長至 210.1 億美元，到 2032 年將達到 422.5 億美元，複合年成長率為 12.02%。

主要市場統計數據
基準年 2025 190.8億美元
預計年份：2026年 210.1億美元
預測年份 2032 422.5億美元
複合年成長率 (%) 12.02%

一份策略性產業概覽，揭示了監管壓力、消費者期望和科學創新如何重新定義畜牧業績效改進策略。

動物生長促進劑和生產力增強劑領域涉及動物健康、農業生產力和消費者期望的交匯點。不斷成長的蛋白質需求、日益完善的動物福利標準以及負責任的抗生素使用，重新定義了整個價值鏈上各相關人員的優先事項。因此，傳統上專注於產量和生長的產品，如今也需要從安全性、殘留、可追溯性和長期畜群性能等方面進行評估。市場參與企業如今面臨著一個多層次的環境，必須確保其科學的功效符合監管要求和市場准入要求。

監管改革、精準劑量技術和消費者主導的可追溯性如何重塑產品創新、夥伴關係和市場定位。

一場重大變革浪潮正在席捲而來，重塑競爭格局，並將產品研發置於優先地位。首先，許多地區日益嚴格的監管推動人們從預防性使用抗生素轉向益生元、益生菌和靶向酶等替代方案。這種日益成長的監管壓力刺激了對非抗生素療法的研發投入，這些療法能夠在保持生產力的同時，降低對抗生素抗藥性細菌的選擇壓力。其次，數位化和精密農業工具能夠更精準地管理和監測生長促進劑，使干涉措施能夠針對特定群體和生命階段進行客製化，從而提高效率並最大限度地減少浪費。

為因應 2025 年關稅造成的衝擊：動物性能增強劑的整個供應鏈被迫轉向本地採購、最佳化配方並與戰略供應商合作。

2025年關稅的實施和貿易政策的調整在全球供應鏈中製造了新的摩擦點，改變了生長促效劑和性能增強劑所用原料的籌資策略和成本結構。對藥品活性成分、特種酸和某些微生物菌株的進口關稅提高，增加了依賴全球原料網路的製造商的接收成本，促使採購團隊盡可能地實現供應商多元化和供應鏈本地化。因此，製造商加快了對替代供應商的認證，並投資建設區域儲備，以確保供應的連續性並減少前置作業時間的波動。

將產品化學特性、劑型、牲畜生理和分銷管道趨勢聯繫起來的細分市場層面的洞察，揭示每個細分市場的獨特引進途徑和發展重點。

市場區隔洞察揭示了每種產品類型、牲畜種類、製劑形式、應用和分銷管道的獨特需求促進因素和發展重點。從產品類型趨勢來看，酸化劑、抗生素、BETA-促效劑、酵素、荷爾蒙、益生元和益生菌各自面臨獨特的科學、監管和市場接受度挑戰。例如，酸化劑研究表明，丁酸、甲酸和丙酸在腸道微生物群管理方面越來越受到關注；而包括離子載體、大環內酯類、青黴素類和四環黴素在內的抗生素仍需遵守合理使用政策，並持續接受嚴格審查。萊克多巴胺和齊帕特羅等BETA-促效劑在某些出口市場仍存在爭議，迫使生產商在療效聲明和准入限制之間尋求平衡。在酵素製劑開發方面，重點在於研發澱粉酶、纖維素酶、植酸酶和蛋白酶的混合物，以從飼料中釋放營養物質並提高飼料轉化率；而以雄激素、雌激素和孕激素為中心的激素療法則日益受到動物福利和殘留物方面的限制。以微生物組為中心的解決方案因其益生元成分（如果寡糖和甘露聚醣）以及益生菌菌株（如雙歧桿菌、乳酸桿菌和酵母菌）而備受關注，這些成分有助於提高動物的抗病能力和生產力。

在美洲、歐洲、中東和非洲以及亞太地區，需要製定單獨的產品文件、現場測試和適應性商業化策略，以應對特定地區的法規和生產實際情況。

美洲、歐洲、中東和非洲（EMEA）以及亞太地區的細微區域差異對監管接受度、採納率和戰略重點產生了顯著影響。在美洲，生產商和監管機構已在提高生產力和履行負責任的管理義務之間找到了切實可行的平衡點，通常能夠將新型飼料添加劑與系統化的監測系統並行引入。相較之下，歐洲、中東和非洲地區的情況則更為複雜；歐洲的管理體制對抗生素的使用和殘留限量要求嚴格，而中東和非洲的一些市場則為推廣適應當地生產系統的、具有成本效益且耐熱的配方提供了機會。在亞太地區，高密度生產系統、技術的快速普及以及強烈的出口導向正在推動對最佳化飼料轉換率和生物安全解決方案的需求，儘管貿易相關的限制可能會使某些複合飼料的核准變得複雜。

競爭格局分析強調研發支援的差異化、策略夥伴關係和供應鏈韌性是動物生產力解決方案領域領導地位的決定因素。

競爭格局由成熟的製藥公司、專業的飼料添加劑創新企業和新興生物技術公司組成。主要企業通常憑藉強大的監管合規能力、廣泛的測試網路以及與整合商和獸醫的深厚關係，實現高效的產品上市速度。同時，敏捷的生物技術和原料專家正在開發基於微生物組的療法、酵素混合物和靶向酸添加技術，這給老牌企業帶來了壓力，迫使它們推動創新並獲得互補能力。大型企業與利基開發商之間的合作已成為加快產品驗證速度和拓展產品系列的常見策略。

為了加快推廣應用並降低風險，我們正在為製造商和經銷商實施切實可行的策略措施，這些措施結合了證據生成、來源多元化、數位服務和監管合規。

行業領導企業應優先採取一系列切實可行的措施，以確保商業性發展勢頭和監管適應能力。首先，投資進行嚴謹的、經同儕審查的實地研究，以證明產品的多方面價值，例如提高飼料轉換率、減少治療性介入、改善殘留物分佈。此類證據將加速產品在一體化市場和出口市場的認可。其次，探索本地化生產和委託製造方案，以加速原料來源多元化，並降低關稅和運輸風險。這些措施將有助於企業維持利潤率，並保障對客戶的持續供應。

我們透過透明、多方面的研究途徑，結合科學文獻、監管分析、現場測試審查和對從業者的訪談，確保提供切實可行的行業見解。

本分析的調查方法結合了多方面的證據分析，交叉引用了同行檢驗的科學文獻、監管文件、市場田間試驗數據以及對獸醫、飼料負責人和採購經理的專家訪談。數據收集重點關注在受控條件下報告性能結果、殘留物檢測以及不同配方功效比較的研究。此外，該方法還納入了來自供應鏈和銷售負責人的定性見解，以了解籌資策略、利潤率壓力和分銷偏好。

未來展望強調，要維持產業長期競爭力，需要嚴謹的證據、強大的供應鏈和一體化的服務模式。

總之，動物生長促效劑和性能增強劑產業正處於轉折點，監管預期、供應鏈現狀和科學創新在此交匯，重新定義價值創造。能夠以嚴謹的數據驗證產品有效性、展現即使在貿易摩擦面前也能保持供應韌性，並提供符合生產者經濟和社會期望的綜合解決方案的企業，才能最終勝出。隨著生產者要求更清晰的性能證據，以及採購商在採購決策中日益重視動物福利和殘留物問題，產品開發商必須調整其技術藍圖和商業性策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：動物生長促效劑與生產力增強劑市場：依產品類型分類

  • 酸味劑
    • 丁酸
    • 甲酸
    • 丙酸
  • 抗生素
    • 離子載體
    • 大環內酯類
    • 青黴素
    • 四環黴素
  • BETA-促效劑
    • 乳糖胺
    • 齊帕特羅
  • 酵素
    • 澱粉酶
    • 纖維素酶
    • 植酸酶
    • 蛋白酶
  • 荷爾蒙
    • 雄激素
    • 雌激素
    • 黃體素
  • 益生元
    • 果寡糖
    • 甘露聚醣
  • 益生菌
    • 雙歧桿菌
    • 乳酸桿菌
    • 釀酒酵母

第9章：以牲畜類型分類的動物生長促效劑和生產力增強劑市場

  • 水產養殖
  • 家禽
  • 反芻動物
  • 豬

第10章：以配方類型分類的動物生長促效劑和生產力增強劑市場

  • 飼料添加劑
  • 注射藥物
  • 飲用水添加物

第11章：動物生長促效劑與生產力增強劑市場：依應用分類

  • 疾病預防
  • 飼料效率
  • 促進生長
  • 生育力

第12章：動物生長促效劑與生產力增強劑市場：依通路分類

  • 直銷
  • 銷售代理
  • 電子商務

第13章 動物生長促效劑與生產力增強劑市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：動物生長促效劑與生產力增強劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 動物生長促效劑和生產力增強劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國動物生長促效劑與生產力增強劑市場

第17章：中國動物生長促效劑與生產力增強劑市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alltech, Inc.
  • Archer Daniels Midland Company
  • BASF SE
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Koninklijke DSM NV
  • Merck & Co., Inc.
  • Nutreco NV
  • Zoetis Inc.
Product Code: MRR-031BF22F9499

The Animal Growth Promoters & Performance Enhancers Market was valued at USD 19.08 billion in 2025 and is projected to grow to USD 21.01 billion in 2026, with a CAGR of 12.02%, reaching USD 42.25 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 19.08 billion
Estimated Year [2026] USD 21.01 billion
Forecast Year [2032] USD 42.25 billion
CAGR (%) 12.02%

A strategic industry overview revealing how regulatory pressure, consumer expectations, and scientific innovation are redefining performance enhancement strategies in livestock production

The animal growth promoters and performance enhancers sector sits at the intersection of animal health, agricultural productivity, and consumer expectations. Rising protein demand, evolving welfare standards, and antimicrobial stewardship initiatives have reshaped stakeholder priorities across the value chain. Consequently, products that traditionally emphasized yield and growth are increasingly evaluated against safety, residues, traceability, and long-term herd performance. Market participants now navigate a multilayered environment where science-driven efficacy must align with regulatory compliance and market access considerations.

Against this backdrop, innovation is moving toward targeted biologicals, enzyme blends, and precision nutrition approaches that support animal resilience and feed efficiency while responding to heightened scrutiny over antibiotic use. At the same time, commercial imperatives push companies to demonstrate measurable outcomes, such as improved conversion ratios and reduced therapeutic interventions, so that producers can justify adoption. In short, the industry is transitioning from single-metric performance claims toward integrated value propositions that combine efficacy, safety, and demonstrable return on investment for producers and supply-chain partners.

How a convergence of regulatory reform, precision delivery technologies, and consumer-driven traceability is reshaping product innovation, partnerships, and market positioning

Significant transformative shifts are underway that reconstitute competitive dynamics and product development priorities. First, regulatory landscapes have tightened in many jurisdictions, prompting a move away from prophylactic antibiotic use and toward alternatives such as prebiotics, probiotics, and targeted enzymes. This regulatory tightening has driven research investment into non-antibiotic modalities that can sustain productivity while reducing selection pressure for resistant organisms. Second, digital and precision agriculture tools are enabling more targeted delivery and monitoring of growth promoters, so interventions can be tailored to specific cohorts and life stages, improving efficacy and minimizing waste.

Meanwhile, supply chain transparency and consumer-facing sustainability claims are forcing manufacturers to substantiate product provenance and residue profiles. As a result, partnerships between feed additive producers, genetic companies, and integrators are becoming more common, with collaborative pilots focusing on holistic performance programs rather than discrete product placements. In addition, capital allocation has shifted toward biologics and microbiome-focused solutions, while legacy chemistries are being reformulated or repositioned for niche use under veterinary oversight. Collectively, these shifts favor agile innovators that can combine regulatory expertise, strong efficacy data, and compelling commercial evidence of value.

Navigating the 2025 tariff-induced disruption that forced regional sourcing, formulation optimization, and strategic supplier partnerships across the animal performance enhancer supply chain

The imposition of tariffs and trade policy adjustments in 2025 created new friction points for global supply chains, altering sourcing strategies and cost structures for inputs used in growth promoters and performance enhancers. Elevated import duties on active pharmaceutical ingredients, specialty acids, and certain microbial strains increased landed costs for manufacturers that rely on global raw material networks, prompting procurement teams to diversify suppliers and regionalize supply chains where feasible. As a result, manufacturers accelerated qualification of alternate suppliers and invested in regional stockpiles to preserve continuity of supply and mitigate lead-time variability.

Moreover, tariff-driven cost pressures spurred renewed emphasis on formulation efficiency and value engineering, encouraging R&D teams to optimize dosing regimens and concentrate formulations to reduce shipping volumes and duty exposure. In parallel, producers seeking to manage input cost volatility explored contractual hedging and long-term supplier agreements. These responses have implications for competitive positioning: firms able to localize production or demonstrate robust supply continuity gained credibility with large integrators, while those dependent on constrained import channels faced margin compression and accelerated innovation imperatives to maintain customer relationships.

Segment-level intelligence that connects product chemistries, delivery formats, livestock physiologies, and channel dynamics to reveal differentiated adoption pathways and development priorities

Insights from segmentation reveal differentiated demand drivers and development priorities across product types, livestock classes, formulation formats, applications, and distribution channels. Product-type dynamics show that acidifiers, antibiotics, beta agonists, enzymes, hormones, prebiotics, and probiotics each face unique scientific, regulatory, and market acceptance challenges; for example, acidifier research increasingly focuses on butyric, formic, and propionic acids for gut health management, while antibiotics continue to be scrutinized with ionophores, macrolides, penicillins, and tetracyclines subject to stewardship policies. Beta agonists such as ractopamine and zilpaterol remain polarizing in certain export markets, prompting manufacturers to balance efficacy claims with access constraints. Enzyme development emphasizes amylase, cellulase, phytase, and protease blends that unlock feed nutrients and improve conversion, and hormonal approaches centered on androgens, estrogens, and progestins are increasingly governed by welfare and residue considerations. Microbiome-focused solutions highlight prebiotic chemistries like fructooligosaccharides and mannan oligosaccharides and probiotic strains such as Bifidobacterium, Lactobacillus, and Saccharomyces that support disease resistance and performance.

When considering livestock type, aquaculture, poultry, ruminants, and swine present distinct physiological and management constraints that determine product selection and dosing strategies, with aquaculture's water-based delivery and poultry's rapid turnover calling for different formulation priorities than ruminant or swine systems. Formulation choices between feed additives, injectables, and water additives influence adoption pathways and veterinarian involvement, while applications across disease prevention, feed efficiency, growth promotion, and reproductive performance require tailored evidence packages and trial designs. Distribution channels comprising direct sales, distributors, and e-commerce each offer trade-offs between control, reach, and service level; for example, high-touch institutional customers may prefer direct relationships for technical support, whereas smaller farms increasingly leverage digital platforms to access packaged solutions.

Region-specific regulatory and production realities that require tailored product dossiers, localized trials, and adaptive commercialization strategies across the Americas, EMEA, and Asia-Pacific

Regional nuances materially influence regulatory tolerance, adoption rates, and strategic priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, producers and regulators display a pragmatic balance between productivity gains and stewardship obligations, often enabling pragmatic rollouts of novel feed additives alongside structured surveillance. Conversely, the Europe, Middle East & Africa region presents a heterogeneous landscape where European regulatory regimes are stringent on antibiotic use and residue limits, while several Middle Eastern and African markets present opportunities for scaling cost-effective, heat-resistant formulations adapted to local production systems. In Asia-Pacific, high-density production systems, rapid technology adoption, and strong export orientation drive demand for solutions that optimize feed conversion and biosecurity, although trade-driven constraints can complicate certain compound approvals.

These geographic dynamics influence investment and commercialization strategies. Manufacturers targeting global accounts must design adaptable dossiers to meet divergent approval pathways, and they must be prepared to differentiate labeling and support packages by region. In addition, regional research partnerships and in-market field trials are essential to demonstrate performance under local conditions and to satisfy importers and retailers who increasingly demand consistent residue and welfare evidence across sourcing geographies.

Competitive landscape analysis emphasizing R&D-backed differentiation, strategic partnerships, and supply chain resilience as decisive factors for leadership in animal performance solutions

Competitive dynamics are defined by a mix of legacy pharmaceutical firms, specialized feed additive innovators, and emerging biotech entrants. Leading players often combine robust regulatory affairs capabilities with expansive trial networks and deep relationships with integrators and veterinarians, which enables efficient pathway-to-market execution. At the same time, nimble biotech companies and ingredient specialists are advancing microbiome therapeutics, enzyme blends, and targeted acidifier technologies, creating pressure on incumbents to innovate or acquire complementary capabilities. Collaboration between large firms and niche developers has become a common strategy to accelerate time-to-evidence and broaden product portfolios.

In addition, strategic differentiation increasingly hinges on value-added services such as digital monitoring, advisory programs, and bundled nutrition plans that demonstrate holistic performance improvements. Firms that invest in high-quality clinical data, transparent residue studies, and clear use instructions gain advantage with export-oriented producers and retailers focused on compliance. Finally, supply chain resilience and the ability to localize manufacturing or source alternate inputs are emerging as competitive levers, given recent trade disruptions and raw material volatility.

Practical strategic moves for manufacturers and distributors that combine evidence generation, supply diversification, digital services, and regulatory alignment to accelerate adoption and reduce risk

Industry leaders should prioritize a set of actionable initiatives to secure commercial momentum and regulatory resilience. First, invest in rigorous, peer-reviewed field studies that demonstrate multi-dimensional value: improved feed efficiency, reduced therapeutic interventions, and robust residue profiles. Such evidence will expedite acceptance among integrators and export markets. Second, accelerate diversification of raw material sources and evaluate regional manufacturing or tolling options to mitigate tariff and transport risks. By doing so, companies can protect margins and assure customers of supply continuity.

Third, develop integrated offerings that combine product efficacy with digital monitoring and advisory services to quantify outcomes and reinforce customer loyalty. Fourth, pursue targeted collaborations with microbiome specialists, enzyme developers, and veterinary networks to expand technical breadth without bearing the full cost of discovery. Fifth, refine regulatory strategies by mapping approval pathways across priority markets and investing in harmonized safety dossiers where feasible. Taken together, these steps will position companies to deliver measurable performance improvements while managing compliance and supply-chain complexity.

A transparent, multi-source research approach combining scientific literature, regulatory analysis, field trial review, and expert practitioner interviews to ensure actionable industry insights

The research methodology underpinning this analysis combines a multi-source evidence approach, triangulating peer-reviewed scientific literature, regulatory filings, in-market field trial data, and expert interviews with veterinarians, feed formulators, and procurement leaders. Data collection emphasized studies that report controlled performance outcomes, residue testing, and comparative efficacy across formulations. In addition, the methodology incorporated qualitative inputs from supply chain and commercial leaders to understand sourcing strategies, margin pressures, and distribution preferences.

Analytical techniques included thematic synthesis of scientific findings, comparative policy analysis to map regulatory divergence across jurisdictions, and scenario planning to assess the operational impact of trade disruptions. Where available, field trial parameters were reviewed to assess statistical robustness and relevance to commercial conditions. Throughout, the approach prioritized transparent assumptions and reproducible reasoning to ensure findings are actionable for both technical and commercial audiences.

A forward-looking synthesis highlighting the necessity of rigorous evidence, resilient supply chains, and integrated service models to sustain long-term industry relevance

In conclusion, the animal growth promoters and performance enhancers sector is at an inflection point where regulatory expectations, supply-chain realities, and scientific innovation converge to redefine value creation. Success will accrue to organizations that can substantiate efficacy with rigorous data, demonstrate supply resilience in the face of trade friction, and deliver integrated solutions that align with producer economics and societal expectations. As producers demand clearer evidence of performance and as buyers increasingly factor welfare and residue considerations into sourcing decisions, product developers must adapt both their technical roadmaps and commercial narratives.

Looking ahead, the most sustainable advances will emerge from cross-disciplinary collaborations that integrate microbiome science, precision nutrition, and digital monitoring, supported by regulatory strategies that anticipate shifting approval criteria. Firms that act now to shore up evidence, localize critical inputs, and build service-oriented propositions will be best positioned to capture long-term relevance and trust across complex global value chains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Growth Promoters & Performance Enhancers Market, by Product Type

  • 8.1. Acidifiers
    • 8.1.1. Butyric Acid
    • 8.1.2. Formic Acid
    • 8.1.3. Propionic Acid
  • 8.2. Antibiotics
    • 8.2.1. Ionophores
    • 8.2.2. Macrolides
    • 8.2.3. Penicillins
    • 8.2.4. Tetracyclines
  • 8.3. Beta Agonists
    • 8.3.1. Ractopamine
    • 8.3.2. Zilpaterol
  • 8.4. Enzymes
    • 8.4.1. Amylase
    • 8.4.2. Cellulase
    • 8.4.3. Phytase
    • 8.4.4. Protease
  • 8.5. Hormones
    • 8.5.1. Androgens
    • 8.5.2. Estrogens
    • 8.5.3. Progestins
  • 8.6. Prebiotics
    • 8.6.1. Fructooligosaccharides
    • 8.6.2. Mannan Oligosaccharides
  • 8.7. Probiotics
    • 8.7.1. Bifidobacterium
    • 8.7.2. Lactobacillus
    • 8.7.3. Saccharomyces

9. Animal Growth Promoters & Performance Enhancers Market, by Livestock Type

  • 9.1. Aquaculture
  • 9.2. Poultry
  • 9.3. Ruminants
  • 9.4. Swine

10. Animal Growth Promoters & Performance Enhancers Market, by Formulation

  • 10.1. Feed Additives
  • 10.2. Injectable Formulations
  • 10.3. Water Additives

11. Animal Growth Promoters & Performance Enhancers Market, by Application

  • 11.1. Disease Prevention
  • 11.2. Feed Efficiency
  • 11.3. Growth Promotion
  • 11.4. Reproductive Performance

12. Animal Growth Promoters & Performance Enhancers Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. E Commerce

13. Animal Growth Promoters & Performance Enhancers Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Growth Promoters & Performance Enhancers Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Growth Promoters & Performance Enhancers Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Animal Growth Promoters & Performance Enhancers Market

17. China Animal Growth Promoters & Performance Enhancers Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alltech, Inc.
  • 18.6. Archer Daniels Midland Company
  • 18.7. BASF SE
  • 18.8. Boehringer Ingelheim International GmbH
  • 18.9. Cargill, Incorporated
  • 18.10. Elanco Animal Health Incorporated
  • 18.11. Evonik Industries AG
  • 18.12. Koninklijke DSM N.V.
  • 18.13. Merck & Co., Inc.
  • 18.14. Nutreco N.V.
  • 18.15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY REPRODUCTIVE PERFORMANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY REPRODUCTIVE PERFORMANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY REPRODUCTIVE PERFORMANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. GCC ANIMAL GROWTH PROMOT